Home GenVec

GenVec

acquired
IPO
Vaccine Developer
Basic
Enterprise Profile

Basic Information

GenVec is a biopharmaceutical company that uses differentiated proprietary technology to create superior therapies and vaccines. GenVec is collaborating with major companies and organizations such as Novartis, Merial, and the U.S. government to support a range of product programs addressing the prevention and treatment of significant human and animal health issues. GenVec’s development programs target therapeutic areas including hearing loss and balance disorders, as well as vaccines for the prevention of infectious diseases such as respiratory syncytial virus (RSV), herpes simplex virus (HSV), dengue fever, influenza, malaria, and human immunodeficiency virus (HIV). In the field of animal health, GenVec is developing a vaccine for foot-and-mouth disease.
GenVec, Inc.
Maryland,United States of America
15~50 people
January 01, 1992
cbyroad@genvec.com

Enterprise Profile

Industrial Sector
New Drug Development Vaccine Formulation Production
Technology
Gene Technology Biotechnology
Concept
Disease Treatment
Application Scenarios
Innovative Drugs Traditional Vaccines (Biological Products for Prevention)